Misago Iliac Study

NCT01016275 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2014-08-06

No results posted yet for this study

Summary

The objective of this clinical study is to evaluate, in a controlled setting, the long-term (up to 24 months) outcome of the self-expanding nitinol rapid-exchange Misago (Terumo) stent in TASC A and B iliac lesions.

Conditions

  • Vascular Lesions

Interventions

DEVICE

Misago (stent placement)

Misago iliac stent

Sponsors & Collaborators

  • Flanders Medical Research Program

    lead NETWORK

Principal Investigators

  • Vladimir Borovicanin, MD · Terumo Europe NV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-10-31
Completion
2013-10-31

Countries

  • Belgium
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01016275 on ClinicalTrials.gov